Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Diabetes

  Free Subscription


11.03.2024

1 Am J Cardiol
2 Am J Clin Nutr
2 Am J Manag Care
2 Am J Ophthalmol
1 Ann Intern Med
1 Atherosclerosis
1 BMC Ophthalmol
1 BMJ
1 Circulation
3 Diabet Med
2 Diabetes Care
17 Diabetes Obes Metab
3 J Clin Endocrinol Metab
1 J Clin Invest
1 J Diabetes Complications
3 J Hypertens
2 JAMA
1 Metabolism
4 N Engl J Med
3 Ophthalmol Retina
7 PLoS One
1 WMJ


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Cardiol

  1. SINGH S, Garg A, Tantry US, Bliden K, et al
    Cardiovascular Outcomes With Empagliflozin and Dapagliflozin in Patients Without Diabetes.
    Am J Cardiol. 2024 Mar 1:S0002-9149(24)00161.
    PubMed         Abstract available


    Am J Clin Nutr

  2. ZELICHA H, Yang J, Henning SM, Huang J, et al
    Effect of cinnamon spice on continuously monitored glycemic response in adults with prediabetes: a 4-week randomized controlled crossover trial.
    Am J Clin Nutr. 2024;119:649-657.
    PubMed         Abstract available

  3. HUBER H, Schieren A, Holst JJ, Simon MC, et al
    Dietary impact on fasting and stimulated GLP-1 secretion in different metabolic conditions - a narrative review.
    Am J Clin Nutr. 2024 Jan 11:S0002-9165(24)00005.
    PubMed         Abstract available


    Am J Manag Care

  4. HOFFMAN AF, Roberson CL, Cohen P, Jackson VL, et al
    Improving glycemic control in diabetes through virtual interdisciplinary rounds.
    Am J Manag Care. 2024;30:e78-e84.
    PubMed         Abstract available

  5. QUACH J, Midlam C, Sell C, Levin-Scherz J, et al
    Out-of-pocket costs for diabetes medications in employer-sponsored health insurance plans.
    Am J Manag Care. 2024;30:107-108.
    PubMed         Abstract available


    Am J Ophthalmol

  6. DAI Y, Zheng D, Zhao J, Wang K, et al
    Macular Neural and Microvascular Alterations in Type 2 Diabetes Without Retinopathy: A SS-OCT Study.
    Am J Ophthalmol. 2024 Feb 28:S0002-9394(24)00090.
    PubMed         Abstract available

  7. JOSEPH S, Selvaraj J, Mani I, Kumaragurupari T, et al
    Diagnostic accuracy of artificial intelligence based automated diabetic retinopathy screening in real-world settings: a systematic review and meta-analysis.
    Am J Ophthalmol. 2024 Mar 2:S0002-9394(24)00066.
    PubMed         Abstract available


    Ann Intern Med

  8. KOUTROUMPAKIS E, Deswal A
    In adults with overweight or obesity and CVD, but without diabetes, semaglutide reduced MACE at a mean 40 mo.
    Ann Intern Med. 2024 Mar 5. doi: 10.7326/J24-0008.
    PubMed         Abstract available


    Atherosclerosis

  9. KIM H, Choi CU, Rhew K, Park J, et al
    Comparative effects of glucose-lowering agents on endothelial function and arterial stiffness in patients with type 2 diabetes: A network meta-analysis.
    Atherosclerosis. 2024;391:117490.
    PubMed         Abstract available


    BMC Ophthalmol

  10. ZENG GQ, Yao YF, Zhong JB, Zhang Y, et al
    The non-linear relationship between serum albumin and diabetic retinopathy in type 2 diabetes mellitus: a secondary analysis based on a cross-sectional study.
    BMC Ophthalmol. 2024;24:94.
    PubMed         Abstract available


    BMJ

  11. TANNE JH
    US food manufacturer can say that eating yogurt reduces risk of type 2 diabetes, says FDA.
    BMJ. 2024;384:q569.
    PubMed        


    Circulation

  12. OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al
    Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA(2)DS(2)-VASc 1: A Nationwide Study.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477.
    PubMed         Abstract available


    Diabet Med

  13. MERWIN RM, Dmitrieva NO, Moskovich AA, Warnick JL, et al
    Profiles of disordered eating behaviour in type 1 diabetes using the DEPS-R and behaviour and glycaemic outcomes in a real-life setting.
    Diabet Med. 2024 Mar 7:e15314. doi: 10.1111/dme.15314.
    PubMed         Abstract available

  14. EMBAYE J, Hennekes M, Snoek F, de Wit M, et al
    Psychometric properties of the Diabetes Eating Problem Survey-Revised among Dutch adults with type 1 diabetes and implications for clinical use.
    Diabet Med. 2024 Mar 4:e15313. doi: 10.1111/dme.15313.
    PubMed         Abstract available

  15. MONROY G, Fernandez C, Altimira L, Barba U, et al
    Postpartum oral glucose tolerance test in women with prior gestational diabetes. Does breastfeeding affect the results? Analysis of hormonal profiles.
    Diabet Med. 2024 Mar 7:e15315. doi: 10.1111/dme.15315.
    PubMed        


    Diabetes Care

  16. SILVA PS, Cavallerano JD, Sun JK, Tolson AM, et al
    Disparities Between Teleretinal Imaging Findings and Patient-Reported Diabetic Retinopathy Status and Follow-Up Eye Care Interval: A 10-Year Prospective Study.
    Diabetes Care. 2024 Mar 8:dc232282. doi: 10.2337/dc23-2282.
    PubMed         Abstract available

  17. SEIFU CN, Immanuel J, Hague WM, Teede H, et al
    Association Between Immediate Treatment of Early Gestational Diabetes Mellitus and Breastfeeding Outcomes: Findings From the TOBOGM Study.
    Diabetes Care. 2024 Mar 5:dc231635. doi: 10.2337/dc23-1635.
    PubMed        


    Diabetes Obes Metab

  18. NERILD HH, Bronden A, Haddouchi AE, Ellegaard AM, et al
    Elucidating the glucose-lowering effect of the bile acid sequestrant sevelamer.
    Diabetes Obes Metab. 2024;26:1252-1263.
    PubMed         Abstract available

  19. HUANG Y, Wang S, Cai C, Huang X, et al
    Retinal vascular density as a potential biomarker of diabetic cerebral small vessel disease.
    Diabetes Obes Metab. 2024 Mar 4. doi: 10.1111/dom.15492.
    PubMed         Abstract available

  20. HELMINK MAG, Hageman SHJ, Eliasson B, Sattar N, et al
    Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model.
    Diabetes Obes Metab. 2024 Mar 8. doi: 10.1111/dom.15531.
    PubMed         Abstract available

  21. SOHN TS, Han KA, Kim Y, Lee BW, et al
    A 52-week efficacy and safety study of enavogliflozin versus dapagliflozin as an add-on to metformin in patients with type 2 diabetes mellitus: ENHANCE-M extension study.
    Diabetes Obes Metab. 2024 Mar 8. doi: 10.1111/dom.15537.
    PubMed         Abstract available

  22. POPOVIC DS, Patoulias D, Karakasis P, Koufakis T, et al
    Effect of tirzepatide on the risk of diabetic retinopathy in type 2 diabetes.
    Diabetes Obes Metab. 2024 Mar 8. doi: 10.1111/dom.15535.
    PubMed        

  23. YANG J, Shangguan Q, Xie G, Yang M, et al
    Sex-specific associations between haemoglobin glycation index and the risk of cardiovascular and all-cause mortality in individuals with pre-diabetes and diabetes: A large prospective cohort study.
    Diabetes Obes Metab. 2024 Mar 7. doi: 10.1111/dom.15541.
    PubMed         Abstract available

  24. IVERSEN E, Christensen KM, Walls AB, Eickhoff MK, et al
    Performance of new and panel CKD-EPI equations in European adults with type 2 diabetes.
    Diabetes Obes Metab. 2024 Mar 6. doi: 10.1111/dom.15536.
    PubMed        

  25. REDDY M, Oliver N
    The role of real-time continuous glucose monitoring in diabetes management and how it should link to integrated personalized diabetes management.
    Diabetes Obes Metab. 2024;26 Suppl 1:46-56.
    PubMed         Abstract available

  26. TURNER LV, Riddell MC
    Pre-dinner walks may be superior to post-dinner walks for glucose time in range in adults with type 1 diabetes on hybrid closed-loop insulin delivery systems.
    Diabetes Obes Metab. 2024 Mar 4. doi: 10.1111/dom.15532.
    PubMed        

  27. HOYT JA, Cozzi E, D'Alessio DA, Thompson CC, et al
    A look at duodenal mucosal resurfacing: Rationale for targeting the duodenum in type 2 diabetes.
    Diabetes Obes Metab. 2024 Mar 4. doi: 10.1111/dom.15533.
    PubMed         Abstract available

  28. BATDORF HM, Lawes LL, Cassagne GA, Fontenot MS, et al
    Accelerated onset of diabetes in non-obese diabetic mice fed a refined high-fat diet.
    Diabetes Obes Metab. 2024 Mar 4. doi: 10.1111/dom.15522.
    PubMed         Abstract available

  29. CHEN GL, Liu Y, Gao XF, Wu KQ, et al
    Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation study.
    Diabetes Obes Metab. 2024;26:1395-1406.
    PubMed         Abstract available

  30. GUY A, Azab AN, Liberty IF, Afawi Z, et al
    Adherence to liraglutide among individuals with overweight and obesity: Patient characteristics and clinical measures.
    Diabetes Obes Metab. 2024;26:1346-1354.
    PubMed         Abstract available

  31. LAU D, Gamble JM
    Suicidality among users of glucagon-like peptide-1 receptor agonists: An emerging signal?
    Diabetes Obes Metab. 2024;26:1150-1156.
    PubMed        

  32. HOPE DCD, Ansari S, Choudhury S, Alexiadou K, et al
    Adaptive infusion of a glucagon-like peptide-1/glucagon receptor co-agonist G3215, in adults with overweight or obesity: Results from a phase 1 randomized clinical trial.
    Diabetes Obes Metab. 2024;26:1479-1491.
    PubMed         Abstract available

  33. BAZYDLO-GUZENDA K, Jarus-Dziedzic K, Gierczak-Pachulska A, Buda P, et al
    First-in-human study of CPL207280, a novel G-protein-coupled receptor 40/free fatty acid receptor 1 agonist, in healthy volunteers after single and multiple administration.
    Diabetes Obes Metab. 2024;26:1376-1385.
    PubMed         Abstract available

  34. CUKIERMAN-YAFFE T, Ramasundarahettige C, Bosch J, Gerstein HC, et al
    Effect of basal insulin and omega 3 fatty acids on cognitive impairment in dysglycaemia: An exploratory analysis of the ORIGIN trial.
    Diabetes Obes Metab. 2024;26:1180-1187.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  35. BOURGONJE AR, Bourgonje MF, Sokooti S, la Bastide-van Gemert S, et al
    Plasma calprotectin and new-onset type 2 diabetes in the general population: a prospective cohort study.
    J Clin Endocrinol Metab. 2024 Mar 4:dgae130. doi: 10.1210.
    PubMed         Abstract available

  36. ALHENC-GELAS F, Marre M
    Young onset type2 diabetes: when gluconeogenesis is overfueled and out of control.
    J Clin Endocrinol Metab. 2024 Mar 5:dgae123. doi: 10.1210.
    PubMed        

  37. LIU W, Cai D, Zhang R, Zhang X, et al
    A randomized clinical trial for meal bolus decision using learning-based control in adults with type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Mar 7:dgae143. doi: 10.1210.
    PubMed         Abstract available


    J Clin Invest

  38. DEFRONZO RA
    SGLT2 inhibitors: cardiorenal metabolic drugs for the ages.
    J Clin Invest. 2024;134:e177625.
    PubMed        


    J Diabetes Complications

  39. TSUR N, Frankel M, Cahn A, Tsur A, et al
    Gestational diabetes and risk of future diabetes in a multi-ethnic population.
    J Diabetes Complications. 2024;38:108720.
    PubMed         Abstract available


    J Hypertens

  40. SASAKI N, Maeda R, Ozono R, Yoshimura K, et al
    Differences in the impact of newly diagnosed type 2 diabetes on cardiovascular mortality between normotensive and hypertensive individuals.
    J Hypertens. 2024;42:610-619.
    PubMed         Abstract available

  41. BARCELLOS PAM, Dall'Agnol A, Sandi GM, Remonti LR, et al
    Dietary approach for the treatment of arterial hypertension in patients with diabetes mellitus.
    J Hypertens. 2024;42:583-593.
    PubMed         Abstract available

  42. WANG R, Zhao J, Li L, Huo Y, et al
    Associations between lipid-lowering drugs and pregnancy and perinatal outcomes: a Mendelian randomization study.
    J Hypertens. 2024;42:727-734.
    PubMed         Abstract available


    JAMA

  43. ALHIARY R, Gabriele S, Kesselheim AS, Tu SS, et al
    Delivery Device Patents on GLP-1 Receptor Agonists.
    JAMA. 2024 Feb 5:e240919. doi: 10.1001/jama.2024.0919.
    PubMed        

  44. RUDER K
    Diabetic Foot Infections and Amputations Are All Too Common-Here's What Could Move the Needle.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1016.
    PubMed        


    Metabolism

  45. ROSENDO-SILVA D, Gomes PB, Rodrigues T, Viana S, et al
    Clinical and molecular profiling of human visceral adipose tissue reveals impairment of vascular architecture and remodeling as an early hallmark of dysfunction.
    Metabolism. 2024;153:155788.
    PubMed         Abstract available


    N Engl J Med

  46. KINNY-KOSTER B, Michalski CW, Loos M
    Digital Technology for Diabetes.
    N Engl J Med. 2024;390:962.
    PubMed        

  47. TUMMINIA A, Gullo D, Frasca F
    Digital Technology for Diabetes.
    N Engl J Med. 2024;390:962-963.
    PubMed        

  48. BERG TJ
    Digital Technology for Diabetes.
    N Engl J Med. 2024;390:963.
    PubMed        

  49. HUGHES MS, Addala A, Buckingham B
    Digital Technology for Diabetes. Reply.
    N Engl J Med. 2024;390:963-964.
    PubMed        


    Ophthalmol Retina

  50. GULKAS S, Salongcay RP, Jacoba CMP, Gomez EDD, et al
    Peripheral and Vitreous Pathology in Ultrawide Field Cameras in Diabetic Eyes.
    Ophthalmol Retina. 2024 Mar 4:S2468-6530(24)00090.
    PubMed        

  51. ALSHAIKHSALAMA AM, Thompson KN, Patrick H, Lee J, et al
    Clinical Characteristics and Surgical Outcomes of Patients Undergoing Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy.
    Ophthalmol Retina. 2024 Mar 4:S2468-6530(24)00087.
    PubMed         Abstract available

  52. KADERLI ST, Piccoli G, Limoli C, Ginelli S, et al
    Clinical features related to optical coherence tomography angiography artifacts in patients with diabetic macular edema.
    Ophthalmol Retina. 2024 Mar 4:S2468-6530(24)00089.
    PubMed         Abstract available


    PLoS One

  53. YUI K, Kanawaku Y, Morita A, Hirakawa K, et al
    Time-frequency analysis reveals an association between the specific nuclear magnetic resonance (NMR) signal properties of serum samples and arteriosclerotic lesion progression in a diabetes mouse model.
    PLoS One. 2024;19:e0299641.
    PubMed         Abstract available

  54. OLSON PS, Ploylearmsang C, Sibounheuang P, Sookaneknun S, et al
    Development of a patient satisfaction questionnaire (PSQ) for diabetes management in Thailand and Lao PDR.
    PLoS One. 2024;19:e0300052.
    PubMed         Abstract available

  55. LIU B, Si J, Qi K, Li D, et al
    Chronic intermittent hypoxia aggravated diabetic cardiomyopathy through LKB1/AMPK/Nrf2 signaling pathway.
    PLoS One. 2024;19:e0296792.
    PubMed         Abstract available

  56. YANG Y, Cai Z, Qiu S, Xu P, et al
    Vision transformer with masked autoencoders for referable diabetic retinopathy classification based on large-size retina image.
    PLoS One. 2024;19:e0299265.
    PubMed         Abstract available

  57. KIM JS, Kim ES, Hwang HS, Jeong KH, et al
    Association between albuminuria and retinal microvascular parameters measured with swept-source optical coherence tomography angiography in patients with diabetic retinopathy.
    PLoS One. 2024;19:e0295768.
    PubMed         Abstract available

  58. SMUDJA M, Milenkovic T, Minakovic I, Zdravkovic V, et al
    Self-care activities in pediatric patients with type 1 diabetes mellitus.
    PLoS One. 2024;19:e0300055.
    PubMed         Abstract available

  59. YAMAMOTO M, Aoki S, Shinoda S, Ishikawa H, et al
    Impact of interpregnancy weight changes and perinatal outcomes: A retrospective study in Japan.
    PLoS One. 2024;19:e0299794.
    PubMed         Abstract available


    WMJ

  60. ZIMMERMANN PN, Baier Manwell LM, Osman F, Feldstein D, et al
    Feasibility Study of a Low-Carbohydrate/Time-Restricted Eating Protocol for Insulin-Using Type 2 Diabetic Patients.
    WMJ. 2024;123:11-17.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.